In an unconventional alliance, North Carolina State Treasurer Dale Folwell, a Republican, spoke on Capitol Hill at a ...

Half a century of advancements in biomedical science paved the way for today's powerful weight-loss drugs like Ozempic -- so ...

Company earnings reported early in the quarter showed growth remained strong, with improved manufacturing volumes and steady ...

Hello Health Rounds Readers! Today we highlight research findings reported at ESMO 2024, the annual meeting of the European ...

Interview with the Milanese immunologist Attilio Speciani. They call it an anti-obesity drug, but it's not just that: in ...

(Reuters) - European shares slipped on Friday after a rally in the previous session spurred by U.S. Federal Reserve's ...

North Carolina’s senators are both calling for increased security protection for former President Donald Trump after a ...

Senator Sanders (I-Vt.) says CEOs of generic drugmakers are willing to sell Novo Nordisk’s (NVO) blockbuster obesity medicine ...

New Yorkers considering taking weight-loss drugs like Wegovy and Ozempic must navigate complex rules for public and private health insurance plans. At the same time, state lawmakers are debating ...

Women who take Wegovy to treat obesity have the greatest likelihood of achieving 10% or more weight loss in a year, according to a Cleveland Clinic study published Friday. Michael Siluk ...

Ozempic and Wegovy are branded versions of semaglutide made by pharmaceutical company Novo Nordisk. Ozempic has been available in Australia for some time but Wegovy was only made available in August.

Amycretin, an oral weight loss pill developed by the makers of Wegovy, led to a 13.1% weight loss over three months in early trial results. Novo Nordisk said its phase 1 trial of a daily dose of ...